Does OSIMERTINIB Cause Rash maculo-papular? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Rash maculo-papular have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.1% of all adverse event reports for OSIMERTINIB.
22
Reports of Rash maculo-papular with OSIMERTINIB
0.1%
of all OSIMERTINIB reports
0
Deaths
12
Hospitalizations
How Dangerous Is Rash maculo-papular From OSIMERTINIB?
Of the 22 reports, 12 (54.5%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Rash maculo-papular Listed in the Official Label?
Yes, Rash maculo-papular is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which OSIMERTINIB Alternatives Have Lower Rash maculo-papular Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN